Correction of hypoalbuminemia after cardiac surgery in children: What level needs to be maintained?
https://doi.org/10.33667/2078-5631-2022-30-27-33
Abstract
Research hypothesis. Maintenance of the target albumin level of less than 25 g/l in the postoperative period in children under 1 year of age does not affect the results of treatment.
Materials and methods. A prospective randomized study included 70 patients after open cardiac surgery from January 2020 to June 2021. Two groups of 35 people were formed. Patients of the main group were transfused with albumin at its level below 25 g/l, the control group – less than 25 g/l. The median age at the time of surgery was 1.0 month in patients of both groups (p = 0.860), the median weight was 3.6 kg (3.0; 5.2) and 3.8 kg (3.1; 5.0) in patients of the main and control groups, respectively (p = 0.900).
Results. At the preoperative stage, as well as in intraoperative parameters reflecting the complexity of the operation (Aristotle score, time of cardiopulmonary bypass and aortic clamping, delayed chest closure), the groups did not differ. On the 3rd and 4th days of the postoperative period, the level of albumin in patients of the main group was significantly lower (p = 0.027 and p = 0.034). Albumin transfusion in the ICU was more often performed in patients of the control group (p = 0.031). We did not find significant differences (time of inotropes use, artificial lung ventilation, stay in the intensive care unit, lethality).
Conclusions. There were no significant differences in mortality between groups with different target levels of albumin. Also, no differences were found that could affect the outcome of the disease. Based on our study, it is impossible to draw conclusions about the course of the postoperative period in children with an albumin level of 25 g/l and below, since such an albumin level was not registered.
About the Authors
V. V. Bazylev
Federal Centre for Cardiovascular Surgery
Russian Federation
Russian Federation
Bazylev Vladlen V., DM Sci (habil.), professor, chief physician
Penza
K. T. Shcheglova
Federal Centre for Cardiovascular Surgery
Russian Federation
Russian Federation
Shcheglova Klara T., anesthesiologist-resuscitator at Dept of Anesthesiology and Resuscitation No. 2
Penza
E. A. Shvetsova
Federal Centre for Cardiovascular Surgery
Russian Federation
Russian Federation
Shvetsova Elena A., anesthesiologist-resuscitator at Dept of Anesthesiology and Resuscitation No. 2
Penza
A. I. Magilevets
Federal Centre for Cardiovascular Surgery
Russian Federation
Russian Federation
Magilevets Anton I., head of Dept of Anesthesiology and Intensive Care No. 2
Penza
M. P. Chuprov
Federal Centre for Cardiovascular Surgery
Russian Federation
Russian Federation
Chuprov Maksim P., PhD Med, anesthesiologist-resuscitator at Dept of Anesthesiology and Resuscitation No. 2
Penza
References
1. Guide to anesthesiology and resuscitation. Ed. by Polushin Yu.S. SPb. 2004. 919 p. (289–310).
2. Shalish W., Olivier F., Aly H., Sant’Anna G. Uses and misuses of albumin during resuscitation and in the neonatal intensive care unit. Semin Fetal Neonatal Med. 2017. Vol. 22, No. 5. P. 328–335. https://doi.org/10.1016/j.siny.2017.07.009
3. Davari P. N., Tabib A., Ghadirian M., Givtaj N. Correlation of Post-Operative Hypoalbuminemia with Outcome of Pediatric Cardiac Surgery. Journal of Tehran University Heart Center. 2009. No. 4. Р. 234–239.
4. Leite H. P., Fisberg M., de Carvalho W. B., de Camargo Carvalho A. C. Serum albumin and clinical outcome in pediatric cardiac surgery. Nutrition. 2005. Vol. 21, No. 5. Р. 553–8. https://doi.org/10.1016/j.nut.2004.08.026
5. Brian L. Erstad. Serum Albumin Levels: Who Needs Them? The Annals of pharmacotherapy. 2020. Vol. 55, No. 6. Р. 798–804. https://doi.org/10.1177/1060028020959348
6. Kulabukhov V. V., Konkin A. A., Utev M. D. Albumine solution and modern concepts of infusion therapy: does the story continue? Messenger of Anesthesiology and Resuscitation, 2019, Vol. 16, No. 4, P. 56–64 (In Russ.). https://doi.org/10.21292/2078–5658–2019–16–4–56–64
7. Wigmore G. J., Anstey J. R., St John A., Greaney J. et al. 20 % Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study). J Cardiothorac Vasc Anesth. 2019. Vol. 33, No. 11. Р. 2920–2927. https://doi.org/10.1053/j.jvca.2019.03.049
8. Dingankar A. R., Cave D. A., Anand V., Sivarajan V. B. et al. Albumin 5 % Versus Crystalloids for Fluid Resuscitation in Children After Cardiac Surgery. Pediatr Crit Care Med. 2018. Vol. 19, No. 9. Р. 846–853. https://doi.org/10.1097/PCC.0000000000001657
9. Maitland K., Kiguli S., Opoka R. O. et al. FEAST Trial Group: Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011. No. 364. Р. 2483–249.
10. Holmes P., Garrood T. Guideline for the Use of Human Albumin Solution (HAS). London. 2015. Р. 22.
11. Kapoor P. M., Narula J., Chowdhury U. K., Kiran U., Taneja S. Serum albumin perturbations in cyanotics after cardiac surgery: Patterns and predictions. Ann Card Anaesth. 2016. No. 19. Р. 300–305.
12. Norms in Pediatrics: A Handbook. Vyalov S. S. 7th ed. M.: MEDpress-inform, 2015. 192 p.
13. Leyderman I. N., Gritsan A. I., Zabolotskikh I. B. et al. Metabolic monitoring and nutritional support in prolonged mechanically ventilated (MV) patients. Clinical guidelines. Russian Journal of Anaesthesiology and Reanimatology. 2019; 4: 5–19 (In Russ.). https://doi.org/10.17116/anaesthesiology20190415
14. Vasil’ev D.A., Bazylev V. V., Evtjushkin I. A. Dynamics of proinflammatory cytokines and C-reactive protein after heart valve replacement in patients with uncomplicated early postoperative period. Cardiology and Cardiovascular Surgery. 2013; 6 (3): 59–63 (in Russ.).
15. Henry B. M., Borasino S., Ortmann L., Figueroa M. et al. Perioperative serum albumin and its influence on clinical outcomes in neonates and infants undergoing cardiac surgery with cardiopulmonary bypass: a multi-centre retrospective study. Cardiol Young. 2019 Jun; 29 (6): 761–767. https://doi.org/10.1017/S1047951119000738
16. Charpentier J., Mira J. P. EARSS Study Group. Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study. Intensive Care Med. 2011. No. 37. Р. 115–438.
17. Singer P., Blaser A. R., Berger M. M. et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019. № 38. Р. 48–79. https://doi.org/10.1016/j.clnu.2018.08.037
Review
For citations:
Bazylev V.V., Shcheglova K.T., Shvetsova E.A., Magilevets A.I., Chuprov M.P. Correction of hypoalbuminemia after cardiac surgery in children: What level needs to be maintained? Medical alphabet. 2022;(30):27-33. (In Russ.) https://doi.org/10.33667/2078-5631-2022-30-27-33
Views:
351
Email this article 